![](/images/graphics-bg.png)
A pragmatic randomized controlled trial comparing pathway-based versus usual care in community-acquired acute kidney injury
Joint Authors
Yusuf, Oyindamola B.
Sadiqi, Muhammad A.
al-Maliki, Abd Allah H.
Ismail, Shirin E.
Qurayshi, Muhammad A.
Balla, Muhammad E.
Karsou, Sulayman
Qurayshi, Rayhan A.
Ahmad, Akram
al-Sulami, Salhah
Khalil, Maryam
Hafiz, Jani
Thomson, Jane E. H.
Zahrani, Ziyad A.
Jasim, Abd al-Hamid
Qadri Mujtaba, K. H.
Abu Najm, Zuhayr
Source
Saudi Journal of Kidney Diseases and Transplantation
Issue
Vol. 28, Issue 6 (31 Dec. 2017), pp.1282-1292, 11 p.
Publisher
Saudi Center for Organ Transplantation
Publication Date
2017-12-31
Country of Publication
Saudi Arabia
No. of Pages
11
Main Subjects
Topics
Abstract EN
Clinical pathways have shown conflicting evidence in improvement of several patient-centered outcomes across different clinical settings.
However, the effectiveness of clinical pathway in management of acute kidney injury (AKI) has not been reported.
Therefore, we aimed to assess the length of hospital stay (LOS) and patient-centered outcomes in community acquired AKI and compared pathway care (PC) versus usual care (UC).
The CHAMP-Path AKI Trial is a pragmatic, parallel, single-blind randomized controlled trial.
Physicians were randomized to provide either UC or PC.
Patients were randomized through a computer-generated sequence.
Allocation was concealed.
Patients presenting to the emergency department with AKI and hemodynamic stability, who were over 14 years with a serum creatinine greater than 1.5 times the baseline were eligible.
Patients with chronic kidney disease stages 4 or 5, kidney transplantation recipients, those admitted with obstructive uropathy, suspected glomerular or interstitial disease, and pregnant women were excluded.
Thirty-eight patients were enrolled from March 2012 to December 2013.
The primary outcome was LOS.
Secondary outcomes included: 30-day re- admission, in-hospital respectively (P = 0.770).
Of the five readmissions, none were for AKI.
No in-hospital mortality was reported.
The CHAMP-Path AKI pragmatic trial demonstrated that PC was not different than UC in reducing LOS.
There was no difference in 30-day readmission, in-hospital mortality, and patient-centered outcomes.
American Psychological Association (APA)
al-Maliki, Abd Allah H.& Ismail, Shirin E.& Qurayshi, Muhammad A.& Abu Najm, Zuhayr& Balla, Muhammad E.& Karsou, Sulayman…[et al.]. 2017. A pragmatic randomized controlled trial comparing pathway-based versus usual care in community-acquired acute kidney injury. Saudi Journal of Kidney Diseases and Transplantation،Vol. 28, no. 6, pp.1282-1292.
https://search.emarefa.net/detail/BIM-785632
Modern Language Association (MLA)
al-Maliki, Abd Allah H.…[et al.]. A pragmatic randomized controlled trial comparing pathway-based versus usual care in community-acquired acute kidney injury. Saudi Journal of Kidney Diseases and Transplantation Vol. 28, no. 6 (Nov. / Dec. 2017), pp.1282-1292.
https://search.emarefa.net/detail/BIM-785632
American Medical Association (AMA)
al-Maliki, Abd Allah H.& Ismail, Shirin E.& Qurayshi, Muhammad A.& Abu Najm, Zuhayr& Balla, Muhammad E.& Karsou, Sulayman…[et al.]. A pragmatic randomized controlled trial comparing pathway-based versus usual care in community-acquired acute kidney injury. Saudi Journal of Kidney Diseases and Transplantation. 2017. Vol. 28, no. 6, pp.1282-1292.
https://search.emarefa.net/detail/BIM-785632
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references : p. 1290-1292
Record ID
BIM-785632